Pharmalot 3.0 is back
Let joy be unbounded.http://blogs.wsj.com/pharmalot/ (Source: PharmaGossip)
Source: PharmaGossip - June 5, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Tut tut GSK
GlaxoSmithKline (GSK) has confirmed it is going to pay a massive fine after admitting it mis-promoted a range of drugs in the US.The pharmaceutical company stated that it will pay $105 million (£63 million) settlement with 44 US states and the District of Columbia following the way the firm promoted anti-depressants Paxil and Wellbutrin and asthma medication Advair.However, GSK did not admit any wrongdoing regarding the promotion of the medication and insisted that the money it is paying out is in relation to previous issues."We don't feel like this is who we are today," GSK spokeswoman Mary Anne Rhyne told the BBC. "Thes...
Source: PharmaGossip - June 5, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Ketamine - A Professor Writes
For the past six months, I've fielded increasingly more questions about ketamine.My patients: "Will ketamine help me?" My colleagues: "Is ketamine safe for my patients?"Ketamine is an FDA- (Food and Drug Administration) approved drug for anesthesia during surgery and for pain relief -- in adults and children. Several studies (including one report published recently) have shown its rapid, positive effects in depression as well as rapid effects in obsessive-compulsive disorder (OCD) -- a persistent and often disabling disorder in which individuals have repetitive thoughts and behaviors.Because ketami...
Source: PharmaGossip - March 24, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Where did all the Prozac data go?
http://www.thesundaytimes.co.uk/sto/news/uk_news/Health/article1390959.ece Paywall (Source: PharmaGossip)
Source: PharmaGossip - March 24, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Plavix and The Five O
Hawaii attorney general sues makers of drug Plavix alleging unfair and deceptive marketingHawaii Attorney General David Louie filed a lawsuit Wednesday in 1st Circuit Court against Bristol-Myers Squibb and Sanofi-Aventis, the manufacturers and distributors of the drug Plavix, alleging unfair and deceptive marketing of the blood-thinning drug to Hawaii consumers.The suit alleges that manufacturers of Plavix, a “blockbuster antiplatelet” drug aimed at preventing strokes and heart attacks, began questionable marketing of the drug back in 1998 for not disclosing information related to how certain g...
Source: PharmaGossip - March 20, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
BBC Reggae The Story of Jamaican Music Programme 1 Forward March
(Source: PharmaGossip)
Source: PharmaGossip - March 20, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Risperdal - ARKANSAS COURT TOSSES $1.2B JUDGMENT AGAINST J&J BY CHUCK BARTELS ASSOCIATED PRESS
LITTLE ROCK, Ark. (AP) -- The Arkansas Supreme Court on Thursday overturned a $1.2 billion judgment against Johnson & Johnson in a lawsuit challenging the drugmaker's marketing of the antipsychotic drug Risperdal.The court ruled that the state improperly sued under a law that applies to health care facilities, not pharmaceutical companies.The ruling comes in an appeal of lawsuit filed by Arkansas against the drugmaker and subsidiary Janssen Pharmaceuticals. The state says the companies didn't properly communicate the drug's risks and marketed it for off-label use, calling the practices fraudulent.Johnson & Johnson ...
Source: PharmaGossip - March 20, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Bob Marley - Small Axe
Why boasteth thyself, oh evil men,Playing smart and not being clever?I say you're working iniquity to achieve vanity, yeah,But the goodness of JAH JAH endureth forever.If you are the big tree,We are the small axe.Sharpened to cut you down,Ready to cut you down.These are the words of my master.Keep on telling meNo weak heart shall prosper,Oh, no they can't.And whosoever diggeth a pit, Lord,Shall fall in it, shall fall in it.Whosoever diggeth a pit shall bury in it,Shall bury in it.If you are the big tree,We are the small axeSharpened to cut you down,Ready to cut you down.And whosoever diggeth a pit shall fall in it, fall in...
Source: PharmaGossip - March 20, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Has NICE joined AllTrials?
The NICE boss has called for “more data transparency” from pharma in a bid to improve the relationship between the pharma and healthcare industries.Speaking at a summit held recently in London, the chief executive of the National Institute for Health and Care Excellence (NICE), Sir Andrew Dillon, called for “more data transparency” from the pharma industry to improve its relationship with the healthcare industry.Sir Andrew, who was speaking at the Economist Pharma Summit, said it would “great” if pharma companies could make evaluation information available before a drug was released on the market to ensure the ...
Source: PharmaGossip - March 19, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Martha Rosenberg writes
This article was posted on Monday, March 17th, 2014 at 2:44pm and is filed underHealth/Medical, Pharmaceuticals. 0 0 51http://dissidentvoice.org/2014/03/big-pharma-helps-milk-lobby-with-dangerous-drug/? (Source: PharmaGossip)
Source: PharmaGossip - March 18, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Doctor Glaxo is here to teach you
GlaxoSmithKline Plc (GSK) plans to hire doctors to educate their peers about its drugs instead of paying external speakers, a further change to its marketing practices following a record fraud settlement in the U.S.The drugmaker is also investing in improving its multichannel marketing strategy through media such as online streaming of educational content, Deirdre Connelly, head of Glaxo’s U.S. pharmaceuticals business, said in an interview in Philadelphia. The changes come at a time when London-based Glaxo is introducing products recently approved to treat skin cancer, HIV and respiratory diseases.Glaxo has been re...
Source: PharmaGossip - March 17, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Novartis gave doctors thousands to prescribe pills, feds allege
GooglePin ItOriginally published: March 15, 2014 7:41 PMUpdated: March 15, 2014 8:26 PMBy KATHLEEN KERR kathleen.kerr@newsday.comAn illuminated logo sits above windows at Novartis AG's headquarters in Basel, Switzerland, on Tuesday, July, 16, 2013. (Credit: Bloomberg / Gianluca Colla)Dr. Howard Brand says he had one goal when he gave a speech at a Miami hotel in the early 2000s -- to tout the diabetes pill Starlix for the pharmaceutical company Novartis.The giant Swiss drugmaker, which reported $57.9 billion in global sales in 2013, paid the Stony Brook endocrinologist $1,500 for his talk at a doctors'...
Source: PharmaGossip - March 16, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
A hell of a mesh
J&J Lawsuit Sheds Light on Link Between Doctors and Device MakersOne lawsuit taking legal precedence on Johnson & Johnson’s (NYSE:JNJ) docket dates back to March 2005, when the pharmaceutical giant’s Ethicon unit introduced the Gynecare Prolift transvaginal mesh device. Several years later, the company’s 2007 annual report touted the device as an “innovative and effective surgical option” for weakened pelvic muscles.The problem was the U.S. Food and Drug Administration did not approve the device for another three years after its initial release. At the time, the company said ...
Source: PharmaGossip - March 16, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Novartis gave doctors thousands to prescribe pills, feds allege
By KATHLEEN KERR kathleen.kerr@newsday.comDr. Howard Brand says he had one goal when he gave a speech at a Miami hotel in the early 2000s -- to tout the diabetes pill Starlix for the pharmaceutical company Novartis.The giant Swiss drugmaker, which reported $57.9 billion in global sales in 2013, paid the Stony Brook endocrinologist $1,500 for his talk at a doctors' meeting, Brand said in an interview. Novartis also paid for Brand's airfare and his weekend hotel stay, he said."It was self-serving, but I also thought it was a benefit to patients," said Brand, who explained that his expenses-paid weekend in Flo...
Source: PharmaGossip - March 16, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
AstraZeneca has now changed its focus, moving from "milestone seeking
behaviour" to "truth seeking behaviour"
http://www.pharmaphorum.com/news/astrazeneca-now-led-by-science-not-commercial-milestones-says-rd-head? (Source: PharmaGossip)
Source: PharmaGossip - March 15, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
